219 related articles for article (PubMed ID: 18625911)
1. Histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced histamine release is enhanced with SHIP-1 knockdown in cultured human mast cell and basophil models.
Langdon JM; Schroeder JT; Vonakis BM; Bieneman AP; Chichester K; Macdonald SM
J Leukoc Biol; 2008 Oct; 84(4):1151-8. PubMed ID: 18625911
[TBL] [Abstract][Full Text] [Related]
2. Distinct characteristics of signal transduction events by histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced priming and activation of human basophils.
Vonakis BM; Macglashan DW; Vilariño N; Langdon JM; Scott RS; MacDonald SM
Blood; 2008 Feb; 111(4):1789-96. PubMed ID: 18042794
[TBL] [Abstract][Full Text] [Related]
3. Src homology 2 domain-containing inositol 5' phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils.
Vonakis BM; Gibbons S; Sora R; Langdon JM; MacDonald SM
J Allergy Clin Immunol; 2001 Nov; 108(5):822-31. PubMed ID: 11692111
[TBL] [Abstract][Full Text] [Related]
4. Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria.
Vonakis BM; Vasagar K; Gibbons SP; Gober L; Sterba PM; Chang H; Saini SS
J Allergy Clin Immunol; 2007 Feb; 119(2):441-8. PubMed ID: 17125820
[TBL] [Abstract][Full Text] [Related]
5. Association of the Src homology 2 domain-containing inositol 5' phosphatase (SHIP) to releasability in human basophils.
MacDonald SM; Vonakis BM
Mol Immunol; 2002 Sep; 38(16-18):1323-7. PubMed ID: 12217402
[TBL] [Abstract][Full Text] [Related]
6. History of Histamine-Releasing Factor (HRF)/Translationally Controlled Tumor Protein (TCTP) Including a Potential Therapeutic Target in Asthma and Allergy.
MacDonald SM
Results Probl Cell Differ; 2017; 64():291-308. PubMed ID: 29149416
[TBL] [Abstract][Full Text] [Related]
7. Effects of ADP-ribosylation of GTP-binding protein by pertussis toxin on immunoglobulin E-dependent and -independent histamine release from mast cells and basophils.
Saito H; Okajima F; Molski TF; Sha'afi RI; Ui M; Ishizaka T
J Immunol; 1987 Jun; 138(11):3927-34. PubMed ID: 2438330
[TBL] [Abstract][Full Text] [Related]
8. Neutrophils and mast cells. Comparison of neutrophil-derived histamine-releasing activity with other histamine-releasing factors.
White MV; Kaplan AP; Haak-Frendscho M; Kaliner M
J Immunol; 1988 Nov; 141(10):3575-83. PubMed ID: 2460539
[TBL] [Abstract][Full Text] [Related]
9. The inositol 5'-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production.
Leung WH; Bolland S
J Immunol; 2007 Jul; 179(1):95-102. PubMed ID: 17579026
[TBL] [Abstract][Full Text] [Related]
10. Effects of PBMC-derived histamine-releasing factors on histamine release from human skin and lung mast cells.
Okayama Y; Brzezińska-Błaszczyk E; Kuna P; Kaplan AP; Church MK
Clin Exp Allergy; 1995 Sep; 25(9):890-5. PubMed ID: 8564728
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of murine and human Histamine-Releasing Factor (HRF/TCTP) and a model for HRF dimerisation in mast cell activation.
Doré KA; Kashiwakura JI; McDonnell JM; Gould HJ; Kawakami T; Sutton BJ; Davies AM
Mol Immunol; 2018 Jan; 93():216-222. PubMed ID: 29216544
[TBL] [Abstract][Full Text] [Related]
12. Cultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: Relationship to expression of Syk and SHIP-2.
Saini SS; Paterniti M; Vasagar K; Gibbons SP; Sterba PM; Vonakis BM
Clin Immunol; 2009 Sep; 132(3):342-8. PubMed ID: 19477690
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 and RANTES inhibit basophil histamine release induced with monocyte chemotactic and activating factor/monocyte chemoattractant peptide-1 and histamine releasing factor.
Alam R; Forsythe PA; Lett-Brown MA; Grant JA
Am J Respir Cell Mol Biol; 1992 Oct; 7(4):427-33. PubMed ID: 1382479
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting phosphatase SHIP-1 enhances suboptimal IgE-mediated activation of human blood basophils but inhibits IgE-mediated activation of cultured human mast cells.
Rasmussen P; Spillner E; Hoffmann HJ
Immunol Lett; 2019 Jun; 210():40-46. PubMed ID: 31004680
[TBL] [Abstract][Full Text] [Related]
15. Mast cells and pulmonary fibrosis. Identification of a histamine releasing factor in bronchoalveolar lavage fluid.
Broide DH; Smith CM; Wasserman SI
J Immunol; 1990 Sep; 145(6):1838-44. PubMed ID: 1697311
[TBL] [Abstract][Full Text] [Related]
16. IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3.
Kuna P; Reddigari SR; Kornfeld D; Kaplan AP
J Immunol; 1991 Sep; 147(6):1920-4. PubMed ID: 1716285
[TBL] [Abstract][Full Text] [Related]
17. Human basophil/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator release.
Stellato C; de Crescenzo G; Patella V; Mastronardi P; Mazzarella B; Marone G
J Allergy Clin Immunol; 1996 Mar; 97(3):838-50. PubMed ID: 8613641
[TBL] [Abstract][Full Text] [Related]
18. Characterization of histamine-releasing activity: role of cytokines and IgE heterogeneity.
Liao TN; Hsieh KH
J Clin Immunol; 1992 Jul; 12(4):248-58. PubMed ID: 1380965
[TBL] [Abstract][Full Text] [Related]
19. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
20. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE.
MacDonald SM; Lichtenstein LM; Proud D; Plaut M; Naclerio RM; MacGlashan DW; Kagey-Sobotka A
J Immunol; 1987 Jul; 139(2):506-12. PubMed ID: 2439589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
